Cargando…
One-Year Efficacy and Safety of Proton-Beam Irradiation Combined with Intravitreal Conbercept for Refractory or Recurrent Polypoidal Choroidal Vasculopathy: A Pilot Study
INTRODUCTION: To investigate the efficacy and safety of proton-beam irradiation (PBI) combined with intravitreal conbercept (IVC) injection for refractory or recurrent polypoidal choroidal vasculopathy (PCV). METHODS: A prospective interventional clinical trial included 12 patients with refractory P...
Autores principales: | Guo, Jingli, Qiu, Xianxin, Tang, Wenyi, Xu, Gezhi, Moyers, Michael. F., Ren, Wei, Xing, Ying, Gao, Jin, Sun, Jiayao, Lu, Jiade, Kong, Lin, Liu, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770763/ https://www.ncbi.nlm.nih.gov/pubmed/34773572 http://dx.doi.org/10.1007/s40123-021-00409-3 |
Ejemplares similares
-
Short-term efficacy of intravitreal conbercept in treatment-naive patients with polypoidal choroidal vasculopathy
por: Peng, Yuting, et al.
Publicado: (2018) -
Short-Term Efficacy in Polypoidal Choroidal Vasculopathy Patients Treated With Intravitreal Aflibercept or Conbercept
por: Xue, Yin, et al.
Publicado: (2022) -
The Efficacy of Conbercept in Polypoidal Choroidal Vasculopathy: A Systematic Review
por: Wang, Yimin, et al.
Publicado: (2020) -
Treatment of polypoidal choroidal vasculopathy with intravitreal bevacizumab monotherapy
por: Tan, Colin S H, et al.
Publicado: (2013) -
Efficacy of Initial vs. Delayed Photodynamic Therapy in Combination With Conbercept for Polypoidal Choroidal Vasculopathy
por: Sun, Zuhua, et al.
Publicado: (2022)